|  Help  |  About  |  Contact Us

Publication : Transcription factors of the alternative NF-κB pathway are required for germinal center B-cell development.

First Author  De Silva NS Year  2016
Journal  Proc Natl Acad Sci U S A Volume  113
Issue  32 Pages  9063-8
PubMed ID  27457956 Mgi Jnum  J:235291
Mgi Id  MGI:5796048 Doi  10.1073/pnas.1602728113
Citation  De Silva NS, et al. (2016) Transcription factors of the alternative NF-kappaB pathway are required for germinal center B-cell development. Proc Natl Acad Sci U S A 113(32):9063-8
abstractText  The NF-kappaB signaling cascade relays external signals essential for B-cell growth and survival. This cascade is frequently hijacked by cancers that arise from the malignant transformation of germinal center (GC) B cells, underscoring the importance of deciphering the function of NF-kappaB in these cells. The NF-kappaB signaling cascade is comprised of two branches, the canonical and alternative NF-kappaB pathways, mediated by distinct transcription factors. The expression and function of the transcription factors of the alternative pathway, RELB and NF-kappaB2, in late B-cell development is incompletely understood. Using conditional deletion of relb and nfkb2 in GC B cells, we here report that ablation of both RELB and NF-kappaB2, but not of the single transcription factors, resulted in the collapse of established GCs. RELB/NF-kappaB2 deficiency in GC B cells was associated with impaired cell-cycle entry and reduced expression of the cell-surface receptor inducible T-cell costimulator ligand that promotes optimal interactions between B and T cells. Analysis of human tonsillar tissue revealed that plasma cells and their precursors in the GC expressed high levels of NF-kappaB2 relative to surrounding lymphocytes. Accordingly, deletion of nfkb2 in murine GC B cells resulted in a dramatic reduction of antigen-specific antibody-secreting cells, whereas deletion of relb had no effect. These results demonstrate that the transcription factors of the alternative NF-kappaB pathway control distinct stages of late B-cell development, which may have implications for B-cell malignancies that aberrantly activate this pathway.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

10 Bio Entities

0 Expression